论文部分内容阅读
Twenty-sixmyastheniagravis(MG)patientsweretreatedwithtripterygiumglycosides(TⅡ),andtheclinicalefficacy,theserumsolubleinterleukin-2receptor(sIL-2R)andtumornecrosisfactor(TNF)levelswereallobservedfromOctober1995toFebruary1997.Itisreportedasfollows.METHODS
Twenty-six myasthenia gravis (MG) patientsweretreatedwithtripterygiumglycosides (T2), andtheclinicalefficacy, theserumsolubleinterleukin-2receptor (sIL-2R) and tumornecrosisfactor (TNF) levelswereallobservedfromOctober199toFebruary1997.Itisreportedasfollows.METHODS